Apostrophe
Apostrophe launched in 2019 as a rebrand of YoDerm (founded 2012), a teledermatology platform connecting patients with board-certified dermatologists who prescribed customized compounded formulations. The brand was acquired by Hims & Hers for $190 million in 2021 and was shut down in March 2025.
Verified reviewer
Apostrophe, by the numbers.
Apostrophe has one product in the DermFND database, which is categorized as a treatment. The most common ingredients observed in the brand's product data include azelaic acid, niacinamide, aloe vera, and vitamin e. Price data for this brand is currently unavailable in the database. The single sample product identified is Azelaic Acid 15%, which carries an average DermFND score of 73.0/100. This profile represents a limited selection of data points within the current database.
Read full methodology →